Baillie Gifford & Co Portfolio
Baillie Gifford & Co is managed by Tom Slater & Lawrence Burns; 13F filer (CIK 0001088875).
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Tom Slater & Lawrence Burns — tracked via quarterly SEC 13F filings · All famous investors
Q2 2021 · 470 positions · Total reported value $205.20B · Top-10 concentration 37.3% · Updated 2026-10-10
Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR
Turnover: 71.8% · 18 new · 178 cut · 13 exited
Active Share (vs S&P 500): 74.7% · vs QQQ: 71.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2021 13F filing, Baillie Gifford & Co disclosed 470 equity positions with a combined reported value of $205.20B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 37.3% of reported value. HoldingsHub classifies the profile as Mega / High Turnover.
The largest disclosed positions as of Q2 2021 were MRNA ($10.78B), TSLA ($10.77B), ILMN ($10.03B). By sector, the heaviest allocations are Consumer Discretionary 29.9%, Technology 23.2%. Versus the prior quarter, allocation shifted toward Health Care (+3.2pp), Technology (+1.3pp) and away from Communication Services (-0.7pp), Real Estate (-0.8pp).
Versus the prior quarter, Baillie Gifford & Co opened 18 new positions, trimmed 178 and fully exited 13, a turnover rate of 71.8% of positions. The portfolio's overlap with the prior quarter was 89% of names.
The largest new positions opened in Q2 2021 were RXRX ($676.02M), OTLY ($582.93M), YMM ($456.09M).
Of the 13 positions fully exited versus the prior quarter, the largest were IAC ($359.11M), IBKR ($300.42M), YEXT ($178.34M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2021)
- RXRX RECURSION PHARMACEUTICALS IN · $676.02M
- OTLY OATLY GROUP AB · $582.93M
- YMM FULL TRUCK ALLIANCE CO LTD · $456.09M
- PPLI PEOPLE INC · $267.45M
- VMEO VIMEO INC · $178.81M
- ZY ZYMERGEN INC · $112.91M
- DLO Dlocal Ltd./Uruguay · $42.02M
- YOU CLEAR SECURE INC · $32.00M
Fully Exited (vs previous quarter)
- IAC IAC Inc. · prev qtr: $359.11M
- IBKR INTERACTIVE BROKERS GROUP IN · prev qtr: $300.42M
- YEXT YEXT INC · prev qtr: $178.34M
- EB EVENTBRITE INC · prev qtr: $86.62M
- BGT BLACKROCK FLOATING RATE INC · prev qtr: $9.81M
- IPHI INPHI CORP · prev qtr: $100.00K
- GLUU GLU MOBILE INC · prev qtr: $68.00K
- PS Pershing Square Inc. · prev qtr: $44.00K
Insider Transactions (Form 4)
Latest Tom Slater & Lawrence Burns buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Baillie Gifford & Co files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 273 positions worth $110.23B in total. HoldingsHub carries 22 quarters of its filings (Q1 2021–Q2 2026).
Portfolio Structure
- 273 positions · $110.23B reported value (Q2 2026)
- Top 10 holdings = 44.7% of reported value
- Largest position: SPCX (SPACE EXPLORATION TECHN CORP) at 8.0%
- Average position size: $403.75M
Sector Tilt
- Information Technology 40.5%
- Consumer Discretionary 31.2%
- Industrials 9.3%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 28 new, 56 added, 177 reduced, 25 exited
- 12 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
45.88M | $10.78B | 5.25% | Add | |
| 2 |
|
15.85M | $10.77B | 5.25% | Reduce | |
| 3 |
|
21.19M | $10.03B | 4.89% | Reduce | |
| 4 |
|
2.51M | $8.65B | 4.21% | Reduce | |
| 5 |
|
5.75M | $8.40B | 4.09% | Reduce | |
| 6 |
|
4.60M | $7.17B | 3.49% | Reduce | |
| 7 |
|
25.73M | $5.84B | 2.84% | Reduce | |
| 8 |
|
20.69M | $5.70B | 2.78% | Reduce | |
| 9 |
|
90.91M | $4.84B | 2.36% | Reduce | |
| 10 |
|
8.13M | $4.29B | 2.09% | Reduce | |
| 11 |
|
5.29M | $4.23B | 2.06% | Reduce | |
| 12 |
|
52.53M | $4.06B | 1.98% | Add | |
| 13 |
|
27.45M | $3.49B | 1.70% | Add | |
| 14 |
|
30.27M | $3.20B | 1.56% | Add | |
| 15 |
|
10.11M | $3.19B | 1.55% | Add | |
| 16 |
|
8.05M | $3.12B | 1.52% | Reduce | |
| 17 |
|
8.00M | $2.78B | 1.35% | Reduce | |
| 18 |
|
9.81M | $2.69B | 1.31% | Add | |
| 19 |
|
20.26M | $2.51B | 1.22% | Add | |
| 20 |
|
10.04M | $2.40B | 1.17% | Reduce | |
| 21 |
|
7.81M | $2.36B | 1.15% | Add | |
| 22 |
|
5.82M | $2.30B | 1.12% | Add | |
| 23 |
|
5.22M | $2.23B | 1.09% | Reduce | |
| 24 |
|
10.26M | $2.12B | 1.03% | Reduce | |
| 25 |
|
9.30M | $2.06B | 1.00% | Add | |
| 26 |
|
5.53M | $2.00B | 0.98% | Add | |
| 27 |
|
7.02M | $1.90B | 0.93% | Add | |
| 28 |
|
3.80M | $1.75B | 0.85% | Add | |
| 29 |
|
10.22M | $1.73B | 0.84% | Add | |
| 30 |
|
682.22K | $1.71B | 0.83% | Reduce | |
| 31 |
|
4.25M | $1.55B | 0.76% | Reduce | |
| 32 |
|
18.60M | $1.55B | 0.75% | Add | |
| 33 |
|
4.03M | $1.54B | 0.75% | Add | |
| 34 |
|
5.94M | $1.53B | 0.74% | Reduce | |
| 35 |
|
35.84M | $1.50B | 0.73% | Add | |
| 36 |
|
4.27M | $1.47B | 0.71% | Reduce | |
| 37 |
|
6.43M | $1.44B | 0.70% | Reduce | |
| 38 |
|
1.53M | $1.41B | 0.69% | Reduce | |
| 39 |
|
8.42M | $1.40B | 0.68% | Add | |
| 40 |
|
3.81M | $1.34B | 0.65% | Add | |
| 41 |
|
8.38M | $1.32B | 0.64% | Add | |
| 42 |
|
5.15M | $1.26B | 0.61% | Reduce | |
| 43 |
|
15.15M | $1.19B | 0.58% | Add | |
| 44 |
|
8.17M | $1.14B | 0.56% | Add | |
| 45 |
|
10.51M | $1.14B | 0.55% | Add | |
| 46 |
|
3.63M | $1.13B | 0.55% | Add | |
| 47 |
|
90.11M | $1.10B | 0.54% | Add | |
| 48 |
|
7.94M | $1.06B | 0.52% | Add | |
| 49 |
|
3.45M | $1.00B | 0.49% | Add | |
| 50 |
|
20.94M | $998.32M | 0.49% | Add | |
FAQ
What did Baillie Gifford & Co buy in 2021-Q2?
In its 2021-Q2 13F filing, Baillie Gifford & Co reported 470 equity positions worth $205.20B in aggregate; its largest disclosed positions were MRNA ($10.78B), TSLA ($10.77B), ILMN ($10.03B).
How large is Baillie Gifford & Co's portfolio?
Baillie Gifford & Co reported $205.20B of long equity holdings across 470 positions as of 2021-Q2. Top-10 holdings account for 37.3% of reported value.
What is Baillie Gifford & Co's investment style?
HoldingsHub classifies the portfolio as Mega / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.